Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection.
| Autor: | Lu HF; The Second Hepatobiliary Surgery Department, Affiliated Hospital of Yangtze University, Jingzhou, 434000, People's Republic of China., Yuan WP, Li M, Huang Q, Liu JP, Li LQ, Zhong JH |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2015 Jul; Vol. 36 (7), pp. 4937-8. Date of Electronic Publication: 2015 May 31. |
| DOI: | 10.1007/s13277-015-3612-y |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink